IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?. Mediterr J Hematol Infect Dis 2017, 9 (1), e2017010. https://doi.org/10.4084/mjhid.2017.010.